Journal article icon

Journal article

Generation of a monoclonal antibody recognizing the heavily glycosylated CD45 protein and its application on identifying circulating tumor cells

Abstract:
Here, we provide direct evidence that using recombinant proteins expressed in eukaryotic cells as antigen is a practical way to generate monoclonal antibodies (mAbs) against heavily glycosylated proteins. Heavily glycosylated proteins are typically difficult targets for mAb generation, being limited by unsatisfactory affinity and low specificity. Using the heavily glycosylated CD45 protein as an example, we demonstrate the entire process of expressing the protein in eukaryotic cells and using it as an antigen to generate CD45-targeting mAbs in mice. The mAbs generated showed robust affinity and specificity, which are crucial factors for differentiate circulating tumor cells from white blood cells in human breast cancer patient samples. Only 1 cell fusion and 2 cyclic sub-cloning steps were necessary before mAbs with satisfactory performance were obtained
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1371/journal.pone.0192506

Authors

More by this author
Role:
Author
ORCID:
0000-0001-8815-1310
More by this author
Role:
Author
ORCID:
0000-0001-6048-5634
More by this author
Role:
Author
ORCID:
0000-0001-6178-3422
More by this author
Role:
Author
ORCID:
0000-0002-8045-5819
More by this author
Role:
Author
ORCID:
0000-0002-4973-7025


Publisher:
Public Library of Science
Journal:
PLoS ONE More from this journal
Volume:
13
Issue:
2
Pages:
e0192506-e0192506
Publication date:
2018-02-09
DOI:
EISSN:
1932-6203
ISSN:
1932-6203


Language:
English
Keywords:
Pubs id:
1268724
Local pid:
pubs:1268724
Source identifiers:
W2789701588
Deposit date:
2025-11-20
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP